Real world treatment patterns, adverse events and healthcare resource utilization and costs among chronic lymphocytic leukemia (CLL) patients in the US

被引：0
|
作者：
Kabadi, Shaum [1 ]
Olufade, Temitope O. [1 ]
Le, Lisa [2 ]
Byfield, Stacey Dacosta [2 ]
机构：
[1] AstraZeneca LP, Gaithersburg, MD USA
[2] Optum, Eden Prairie, MN USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
154
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [21] Real-world treatment patterns in first line and relapsed Chronic Lymphocytic Leukemia (CLL)
    Feinberg, Bruce
    Schenkel, Brad
    McBride, Ali
    Ellis, Lorie
    Radtchenko, Janna
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S204 - S205
  • [22] Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma
    Dharmani, Charles
    Unni, Sudhir
    Pham, Ngan
    Shaikh, Nazneen Fatima
    Xiong, Yan
    Vashi, Rohan
    Fofah, Oluwatosin
    Strubing, Alessandria
    Salas, Maribel
    Tu, Nora
    Wooddell, Margaret
    Zhou, Xiaoyu
    Near, Aimee
    [J]. FUTURE ONCOLOGY, 2024, 20 (15) : 1013 - 1030
  • [23] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE UNITED STATES
    Pizzicato, Lia
    Nadipelli, Vijay R.
    Samuel, Governor
    Mao, Jianbin
    Lanes, Stephan
    Butler, John
    Pepe, Rebecca S.
    Phatak, Hemant
    El-Kersh, Karim
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1677 - 1677
  • [24] Real-World Health Care Utilization and Costs Among Patients Newly Initiating Systemic Therapy for Chronic Lymphocytic Leukemia (CLL) in the United States
    Matasar, Matthew J.
    Byfield, Stacey Dacosta
    Blauer-Peterson, Cori
    Montez, Melissa
    Reyes, Carolina
    Masaquel, Anthony
    [J]. BLOOD, 2016, 128 (22)
  • [25] Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study (vol 37, pg 3129, 2020)
    Kabadi, Shaum M.
    Near, Aimee
    Wada, Keiko
    Burudpakdee, Chakkarin
    [J]. ADVANCES IN THERAPY, 2020, 37 (07) : 3149 - 3149
  • [26] TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF CARE AMONG PATIENTS WITH NEWLY DIAGNOSED SYSTOLIC AND DIASTOLIC HEART FAILURE IN A US REAL-WORLD SETTING
    Nguyen, C.
    Zhang, X.
    Evers, T.
    Willey, V. J.
    Tan, H.
    Power, T. P.
    [J]. VALUE IN HEALTH, 2019, 22 : S129 - S129
  • [27] REAL-WORLD COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND COSTS BETWEEN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH FIRST-LINE IBRUTINIB OR ACALABRUTINIB
    Rogers, K. A.
    Qureshi, Z. P.
    Ding, Z.
    Emond, B.
    Gogna, P.
    Lafeuille, M. H.
    Bokun, A.
    Fradley, M.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S63 - S63
  • [28] Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USA
    Grivas, Petros
    DerSarkissian, Maral
    Shenolikar, Rahul
    Laliberte, Francois
    Doleh, Yunes
    Duh, Mei Sheng
    [J]. FUTURE ONCOLOGY, 2019, 15 (33) : 3809 - 3818
  • [29] Real world treatment patterns, healthcare resource utilization (HRU), and costs among Waldenstrom macroglobulinemia (WM) patients initiating therapy.
    Ellis, Lorie
    Byfield, Stacey DaCosta
    Korrer, Stephanie
    Schenkel, Brad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors
    Huynh, Lynn
    Cai, Beilei
    Cheng, Mu
    Lax, Angie
    Lejeune, Dominique
    Duh, Mei S.
    Kim, Michelle K.
    [J]. PANCREAS, 2019, 48 (09) : 1126 - 1135
12345